Champions Oncology Stock Price on March 12, 2024
| CSBR Stock | USD 4.53 0.03 0.67% |
Below is the normalized historical share price chart for Champions Oncology extending back to November 29, 1988. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Champions Oncology stands at 4.53, as last reported on the 2nd of June, with the highest price reaching 4.64 and the lowest price hitting 4.53 during the day.
If you're considering investing in Champions Stock, it is important to understand the factors that can impact its price. Champions Oncology secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14% return per unit of standard deviation over the last 3 months. Champions Oncology exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Champions Oncology's risk adjusted performance of (0.09), and Mean Deviation of 1.76 to double-check the risk estimate we provide.
At this time, Champions Oncology's Total Stockholder Equity is relatively stable compared to the past year. As of 06/02/2024, Common Stock Total Equity is likely to grow to about 24.7 K, while Capital Stock is likely to drop slightly above 14.5 K. . At this time, Champions Oncology's Price Book Value Ratio is relatively stable compared to the past year. As of 06/02/2024, Price To Operating Cash Flows Ratio is likely to grow to 15.72, though Price Earnings Ratio is likely to grow to (10.55). Champions Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of January 2003 | 200 Day MA 5.5932 | 50 Day MA 4.902 | Beta 0.394 |
Champions |
Sharpe Ratio = -0.1374
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CSBR |
Estimated Market Risk
| 2.3 actual daily | 20 80% of assets are more volatile |
Expected Return
| -0.32 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Champions Oncology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Champions Oncology by adding Champions Oncology to a well-diversified portfolio.
Price Book 6.7705 | Enterprise Value Ebitda (10.47) | Price Sales 1.3808 | Shares Float 4.7 M | Wall Street Target Price 6 |
Champions Oncology Main Headline on 12th of March 2024
Champions Oncology Reports Quarterly Revenue of 12.0 Million by accesswire.com
HACKENSACK, NJ ACCESSWIRE March 12, 2024 Champions Oncology, Inc. , a global preclinical and clinical research services provider that offers end-to-end oncology solutions, today ann
Champions Oncology Valuation on March 12, 2024
It is possible to determine the worth of Champions Oncology on a given historical date. On March 12, 2024 Champions was worth 5.61 at the beginning of the trading date compared to the closed value of 5.67. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Champions Oncology stock. Still, in general, we apply an absolute valuation method to find Champions Oncology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Champions Oncology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Champions Oncology's related companies.
| Open | High | Low | Close | Volume | |
| 5.62 | 5.62 | 5.60 | 5.62 | 4,135 | |
03/12/2024 | 5.61 | 5.76 | 5.61 | 5.67 | 5,551 |
| 5.15 | 5.69 | 5.15 | 5.50 | 17,753 |
| Backtest Champions Oncology | | | Champions Oncology History | | | Champions Oncology Valuation | Previous | Next |
Champions Oncology Trading Date Momentum on March 12, 2024
| On March 13 2024 Champions Oncology was traded for 5.50 at the closing time. The top price for the day was 5.69 and the lowest listed price was 5.15 . The trading volume for the day was 17.8 K. The trading history from March 13, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 3.00% . The overall trading delta against the current closing price is 6.53% . |
Champions Oncology Fundamentals Correlations and Trends
By evaluating Champions Oncology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Champions Oncology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Champions financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Champions Oncology Stock history
Champions Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Champions is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Champions Oncology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Champions Oncology stock prices may prove useful in developing a viable investing in Champions Oncology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 15.6 M | 16.4 M | |
| Net Loss | -6.1 M | -6.4 M |
Champions Oncology Stock Technical Analysis
Champions Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Champions Oncology Period Price Range
Low | March 12, 2024
| High |
5.61 | 5.67 |
Champions Oncology June 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Champions Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Champions Oncology shares will generate the highest return on investment. By undertsting and applying Champions Oncology stock market strength indicators, traders can identify Champions Oncology entry and exit signals to maximize returns
Champions Oncology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Champions Oncology's price direction in advance. Along with the technical and fundamental analysis of Champions Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Champions to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.37) | |||
| Total Risk Alpha | (0.52) | |||
| Treynor Ratio | 1.72 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Champions Oncology. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in Champions Stock, please use our How to Invest in Champions Oncology guide.Note that the Champions Oncology information on this page should be used as a complementary analysis to other Champions Oncology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Champions Stock analysis
When running Champions Oncology's price analysis, check to measure Champions Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Champions Oncology is operating at the current time. Most of Champions Oncology's value examination focuses on studying past and present price action to predict the probability of Champions Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Champions Oncology's price. Additionally, you may evaluate how the addition of Champions Oncology to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is Champions Oncology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Champions Oncology. If investors know Champions will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Champions Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.29) | Earnings Share (0.72) | Revenue Per Share 3.634 | Quarterly Revenue Growth (0.06) | Return On Assets (0.17) |
The market value of Champions Oncology is measured differently than its book value, which is the value of Champions that is recorded on the company's balance sheet. Investors also form their own opinion of Champions Oncology's value that differs from its market value or its book value, called intrinsic value, which is Champions Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Champions Oncology's market value can be influenced by many factors that don't directly affect Champions Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Champions Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Champions Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Champions Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.